Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8227758rdf:typepubmed:Citationlld:pubmed
pubmed-article:8227758lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:8227758lifeskim:mentionsumls-concept:C0006949lld:lifeskim
pubmed-article:8227758lifeskim:mentionsumls-concept:C0085217lld:lifeskim
pubmed-article:8227758lifeskim:mentionsumls-concept:C0525045lld:lifeskim
pubmed-article:8227758lifeskim:mentionsumls-concept:C0199176lld:lifeskim
pubmed-article:8227758lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:8227758lifeskim:mentionsumls-concept:C0205251lld:lifeskim
pubmed-article:8227758pubmed:issue4lld:pubmed
pubmed-article:8227758pubmed:dateCreated1993-12-3lld:pubmed
pubmed-article:8227758pubmed:abstractTextThe prophylactic efficacy of carbamazepine slow release (CBZ) at ke different blood levels and lithium carbonate slow release (LI) was compared in a retrospective/prospective, randomized, 2-year open trial. 84 patients with a DSM-III-R diagnosis of recurrent affective disorder who had no prophylactic medication in the 2 years preceding the trial (no LI nonresponders), were randomly allocated to three treatment groups: CBZ low (15-25 mumol/l), CBZ high (28-40 mumol/l) and LI (0.6-0.8 mumol/l). Fifty-eight patients completed the full observation period of 2 years, 26 patients dropped out. There were no statistically significant differences in the efficacy of the prophylactic treatment for bipolar patients. For the unipolar patients, the group with a low CBZ serum level showed no reduction in the duration of episodes. The two other treatment groups seem to be equal in attenuation of a unipolar course of an affective disorder.lld:pubmed
pubmed-article:8227758pubmed:languageenglld:pubmed
pubmed-article:8227758pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8227758pubmed:citationSubsetIMlld:pubmed
pubmed-article:8227758pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8227758pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8227758pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8227758pubmed:statusMEDLINElld:pubmed
pubmed-article:8227758pubmed:monthAuglld:pubmed
pubmed-article:8227758pubmed:issn0165-0327lld:pubmed
pubmed-article:8227758pubmed:authorpubmed-author:SimhandlCClld:pubmed
pubmed-article:8227758pubmed:authorpubmed-author:ThauKKlld:pubmed
pubmed-article:8227758pubmed:authorpubmed-author:DenkEElld:pubmed
pubmed-article:8227758pubmed:issnTypePrintlld:pubmed
pubmed-article:8227758pubmed:volume28lld:pubmed
pubmed-article:8227758pubmed:ownerNLMlld:pubmed
pubmed-article:8227758pubmed:authorsCompleteYlld:pubmed
pubmed-article:8227758pubmed:pagination221-31lld:pubmed
pubmed-article:8227758pubmed:dateRevised2009-9-28lld:pubmed
pubmed-article:8227758pubmed:meshHeadingpubmed-meshheading:8227758-...lld:pubmed
pubmed-article:8227758pubmed:meshHeadingpubmed-meshheading:8227758-...lld:pubmed
pubmed-article:8227758pubmed:meshHeadingpubmed-meshheading:8227758-...lld:pubmed
pubmed-article:8227758pubmed:meshHeadingpubmed-meshheading:8227758-...lld:pubmed
pubmed-article:8227758pubmed:meshHeadingpubmed-meshheading:8227758-...lld:pubmed
pubmed-article:8227758pubmed:meshHeadingpubmed-meshheading:8227758-...lld:pubmed
pubmed-article:8227758pubmed:meshHeadingpubmed-meshheading:8227758-...lld:pubmed
pubmed-article:8227758pubmed:meshHeadingpubmed-meshheading:8227758-...lld:pubmed
pubmed-article:8227758pubmed:meshHeadingpubmed-meshheading:8227758-...lld:pubmed
pubmed-article:8227758pubmed:meshHeadingpubmed-meshheading:8227758-...lld:pubmed
pubmed-article:8227758pubmed:meshHeadingpubmed-meshheading:8227758-...lld:pubmed
pubmed-article:8227758pubmed:meshHeadingpubmed-meshheading:8227758-...lld:pubmed
pubmed-article:8227758pubmed:meshHeadingpubmed-meshheading:8227758-...lld:pubmed
pubmed-article:8227758pubmed:meshHeadingpubmed-meshheading:8227758-...lld:pubmed
pubmed-article:8227758pubmed:meshHeadingpubmed-meshheading:8227758-...lld:pubmed
pubmed-article:8227758pubmed:meshHeadingpubmed-meshheading:8227758-...lld:pubmed
pubmed-article:8227758pubmed:meshHeadingpubmed-meshheading:8227758-...lld:pubmed
pubmed-article:8227758pubmed:year1993lld:pubmed
pubmed-article:8227758pubmed:articleTitleThe comparative efficacy of carbamazepine low and high serum level and lithium carbonate in the prophylaxis of affective disorders.lld:pubmed
pubmed-article:8227758pubmed:affiliationUniversity Clinic of Vienna, Department of Psychiatry, Austria.lld:pubmed
pubmed-article:8227758pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8227758pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8227758pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:8227758pubmed:publicationTypeRandomized Controlled Triallld:pubmed